Sarepta Therapeutics Inc (SRPT)

Inventory turnover

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Cost of revenue (ttm)	US$ in thousands	530,142	513,430	501,699	457,832	493,584	454,710	409,712	370,552	288,583	287,866	295,843	305,577	306,904	318,537	313,950	314,056	307,813	285,661	268,473	246,088
Inventory	US$ in thousands	373,530	322,859	244,011	226,876	202,675	203,968	221,192	208,095	198,997	186,212	288,469	268,756	240,333	231,961	220,118	179,650	173,168	171,379	166,360	156,569
Inventory turnover		1.42	1.59	2.06	2.02	2.44	2.23	1.85	1.78	1.45	1.55	1.03	1.14	1.28	1.37	1.43	1.75	1.78	1.67	1.61	1.57

March 31, 2024 calculation

Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $530,142K ÷ $373,530K
= 1.42

The inventory turnover of Sarepta Therapeutics Inc has fluctuated over the past several quarters. The company's inventory turnover ratio has ranged from a low of 1.03 in the third quarter of 2021 to a high of 2.44 in the first quarter of 2023.

Overall, Sarepta's inventory turnover has shown a general trend of improvement over the past five quarters, with the ratio generally increasing from the third quarter of 2021 to the first quarter of 2023. This indicates that the company has been more efficient in managing its inventory levels and turning over its inventory into sales.

However, there was a slight decrease in inventory turnover in the most recent quarter, dropping from 1.59 in the fourth quarter of 2023 to 1.42 in the first quarter of 2024. This could suggest potential challenges in managing inventory effectively or changes in sales patterns that impacted the turnover ratio.

In conclusion, while there have been fluctuations in Sarepta Therapeutics Inc's inventory turnover ratio, overall improvements have been observed in recent quarters. It will be important to monitor future trends to understand the company's effectiveness in managing its inventory levels and optimizing its cash flow.